Published in Cancer Weekly, February 2nd, 2010
"We evaluated the relative importance of MGMT activity, MMR deficiency, nonhomologous end...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.